The prospects of microphysiological systems in modeling platelet pathophysiology in cancer

References

• de Gaetano G. Historical overview of the role of platelets in hemostasis and thrombosis. Haematologica. 2001;86(4):349–8.
   PubMed Web of Science ®Google Scholar
• Francis JL, Biggerstaff J, Amirkhosravi A. Hemostasis and malignancy. Semin Thromb Hemost. 1998;24(2):93–109. doi:10.1055/s-2007-995829.
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz MZ, Sierko E, Kisiel W. The role of hemostatic system inhibitors in malignancy. Semin Thromb Hemost. 2007;33(7):621–642. doi:10.1055/s-2007-991530.
   PubMed Web of Science ®Google Scholar
• Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev. 1992;11(3–4):237–248. doi:10.1007/BF01307180.
   PubMed Web of Science ®Google Scholar
• Symbas NP, Townsend MF, El‐Galley R, Keane TE, Graham SD, Petros JA. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int. 2000;86(3):203–207. doi:10.1046/j.1464-410x.2000.00792.x.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, Tatsuta M, Satomi T. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol. 2002;9(3):287–291. doi:10.1007/BF02573067.
   PubMed Web of Science ®Google Scholar
• Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366(7):610–618. doi:10.1056/NEJMoa1110352.
   PubMed Web of Science ®Google Scholar
• Cheng J, Zeng Z, Ye Q, Zhang Y, Yan R, Liang C, Wang J, Li M, Yi M. The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(15):24327–24336. doi:10.18632/oncotarget.15358.
   PubMedGoogle Scholar
• Jósa V, Krzystanek M, Vass T, Lang T, Juhász V, Szilágyi K, Tihanyi B, Harsányi L, Szállási Z, Salamon F, et al. Thrombocytosis of liver metastasis from colorectal cancer as predictive factor. Pathol Oncol Res. 2015;21(4):991–997. doi:10.1007/s12253-015-9925-8.
   PubMed Web of Science ®Google Scholar
• Barlow M, Hamilton W, Ukoumunne OC, Bailey SER. The association between thrombocytosis and subtype of lung cancer: a systematic review and meta-analysis. Transl Cancer Res. 2021;10(3):1249–1260. doi:10.21037/tcr-20-3287.
   PubMed Web of Science ®Google Scholar
• Wang YH, Deng SJ, Yang YD, Yao N, Zhao JM, Min GT, Wang J, Xu TF, Zhao PY, Wang HP, et al. The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis. Biomark Med. 2017;11(2):195–210. doi:10.2217/bmm-2016-0214.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang H, Zhang B, Zhang L, Wang C. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer. Oncotarget. 2017;8(9):15632–15641. doi:10.18632/oncotarget.14921.
   PubMedGoogle Scholar
• Liebman HA. Thrombocytopenia in cancer patients. Thromb Res. 2014;133(Suppl 2):S63–S69. doi:10.1016/S0049-3848(14)50011-4.
   PubMedGoogle Scholar
• Honn KV, Tang DG, Crissman JD. Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev. 1992;11(3–4):325–351. doi:10.1007/BF01307186.
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz MZ, Sierko E, Klement P, Rak J. The hemostatic system and angiogenesis in malignancy. Neoplasia. 2001;3(5):371–384. doi:10.1038/sj.neo.7900184.
   PubMed Web of Science ®Google Scholar
• Yu L, Guo Y, Chang Z, Zhang D, Zhang S, Pei H, Pang J, Zhao ZJ, Chen Y. Bidirectional interaction between cancer cells and platelets provides potential strategies for cancer therapies. Front Oncol. 2021;11:764119. doi:10.3389/fonc.2021.764119.
   PubMed Web of Science ®Google Scholar
• Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007;110(6):1723–1729. doi:10.1182/blood-2006-10-053736.
   PubMed Web of Science ®Google Scholar
• Zuchtriegel G, Uhl B, Puhr-Westerheide D, Pörnbacher M, Lauber K, Krombach F, Reichel CA, Bhandoola A. Platelets guide leukocytes to their sites of extravasation. PLoS Biol. 2016;14(5):e1002459. doi:10.1371/journal.pbio.1002459.
   PubMed Web of Science ®Google Scholar
• Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost. 2015;114(3):449–458. doi:10.1160/TH14-12-1067.
   PubMed Web of Science ®Google Scholar
• Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359(6398):848–851. doi:10.1038/359848a0.
   PubMed Web of Science ®Google Scholar
• da Costa Martins PA, van Gils JM, Mol A, Hordijk PL, Zwaginga JJ. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J Leukoc Biol. 2006;79(3):499–507. doi:10.1189/jlb.0605318.
   PubMed Web of Science ®Google Scholar
• Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17(5):302–317. doi:10.1038/nrc.2017.6.
   PubMed Web of Science ®Google Scholar
• Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, Ware J, Ruggeri ZM, Jain RK, Folkman J, Wagner DD. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci USA. 2006;103(4):855–860. doi:10.1073/pnas.0510412103.
   PubMed Web of Science ®Google Scholar
• Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer. 2003;103(5):642–646. doi:10.1002/ijc.10833.
   PubMed Web of Science ®Google Scholar
• Lakka Klement G, Yip T-T, Cassiola F, Kikuchi L, Cervi D, Podust V, Italiano JE, Wheatley E, Abou-Slaybi A, Bender E, et al. Platelets actively sequester angiogenesis regulators. Blood. 2009;113(12):2835–2842. doi:10.1182/blood-2008-06-159541.
   PubMed Web of Science ®Google Scholar
• Kuznetsov HS, Marsh T, Markens BA, Castaño Z, Greene-Colozzi A, Hay SA, Brown V, Richardson AL, Signoretti S, Battinelli EM, et al. Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. Cancer Discov. 2012;2(12):1150–1165. doi:10.1158/2159-8290.CD-12-0216.
   PubMed Web of Science ®Google Scholar
• Bodó I, Eikenboom J, Montgomery R, Patzke J, Schneppenheim R, Di Paola J. Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(7):1345–1350. doi:10.1111/jth.12964.
   PubMed Web of Science ®Google Scholar
• Pipili-Synetos E, Papadimitriou E, Maragoudakis ME. Evidence that platelets promote tube formation by endothelial cells on matrigel. Br J Pharmacol. 1998;125(6):1252–1257. doi:10.1038/sj.bjp.0702191.
   PubMed Web of Science ®Google Scholar
• Garcia BA, Smalley DM, Cho, Shabanowitz J, Ley K, Hunt DF. The platelet microparticle proteome. J Proteome Res. 2005;4(5):1516–1521. doi:10.1021/pr0500760.
   PubMed Web of Science ®Google Scholar
• Żmigrodzka M, Guzera M, Miśkiewicz A, Jagielski D, Winnicka A. The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression. Tumour Biol. 2016;37(11):14391–14401. doi:10.1007/s13277-016-5358-6.
   PubMedGoogle Scholar
• Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, Vestweber D, Massberg S, Schönberger T, Pfisterer I, et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res. 2006;98(2):e2–e10. doi:10.1161/01.RES.0000201285.87524.9e.
   PubMed Web of Science ®Google Scholar
• Li R, Ren M, Chen N, Luo M, Deng X, Xia J, Yu G, Liu J, He B, Zhang X, et al. Presence of intratumoral platelets is associated with tumor vessel structure and metastasis. BMC Cancer. 2014;14:167. doi:10.1186/1471-2407-14-167.
   PubMed Web of Science ®Google Scholar
• Shirai T, Revenko AS, Tibbitts J, Ngo ATP, Mitrugno A, Healy LD, Johnson J, Tucker EI, Hinds MT, Coussens LM, et al. Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice. Blood Adv. 2019;3(20):3080–3091. doi:10.1182/bloodadvances.2019000250.
   PubMed Web of Science ®Google Scholar
• Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11(2):123–134. doi:10.1038/nrc3004.
   PubMed Web of Science ®Google Scholar
• Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 1998;153(3):865–873. doi:10.1016/S0002-9440(10)65628-3.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Hafner M, Echtenacher B, Männel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999;59:1295–1300.
   PubMed Web of Science ®Google Scholar
• Morvan MG, Lanier LL. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer. 2016;16(1):7–19. doi:10.1038/nrc.2015.5.
   PubMed Web of Science ®Google Scholar
• Zaslavsky A, Baek KH, Lynch RC, Short S, Grillo J, Folkman J, Italiano JE Jr, Ryeom S. Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood. 2010;115(22):4605–4613. doi:10.1182/blood-2009-09-242065.
   PubMed Web of Science ®Google Scholar
• Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV. Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev. 2014;33(1):231–269. doi:10.1007/s10555-014-9498-0.
   PubMed Web of Science ®Google Scholar
• Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA. 1968;61(1):46–52. doi:10.1073/pnas.61.1.46.
   PubMed Web of Science ®Google Scholar
• Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Jirousková M, Degen JL. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood. 2005;105(1):178–185. doi:10.1182/blood-2004-06-2272.
   PubMed Web of Science ®Google Scholar
• Placke T, Örgel M, Schaller M, Jung G, Rammensee HG, Kopp HG, Salih HR. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res. 2012;72(2):440–448. doi:10.1158/0008-5472.CAN-11-1872.
   PubMed Web of Science ®Google Scholar
• Maurer S, Kropp KN, Klein G, Steinle A, Haen SP, Walz JS, Hinterleitner C, Märklin M, Kopp HG, Salih HR. Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells. Oncoimmunology. 2018;7(2):e1364827. doi:10.1080/2162402X.2017.1364827.
   PubMed Web of Science ®Google Scholar
• Yu LX, Yan L, Yang W, Wu FQ, Ling Y, Chen SZ, Tang L, Tan YX, Cao D, Wu MC, et al. Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein. Nat Commun. 2014;5(1):5256. doi:10.1038/ncomms6256.
   PubMedGoogle Scholar
• Patmore S, Dhami SPS, O’Sullivan JM. Von Willebrand factor and cancer; metastasis and coagulopathies. J Thromb Haemostasis. 2020;18(10):2444–2456. doi:10.1111/jth.14976.
   PubMed Web of Science ®Google Scholar
• Geddings JE, Hisada Y, Boulaftali Y, Getz TM, Whelihan M, Fuentes R, Dee R, Cooley BC, Key NS, Wolberg AS, et al. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J Thromb Haemost. 2016;14(1):153–166. doi:10.1111/jth.13181.
   PubMed Web of Science ®Google Scholar
• Lazarova M, Steinle A. Impairment of NKG2D-Mediated tumor Immunity by TGF-β. Front Immunol. 2019;10:2689. doi:10.3389/fimmu.2019.02689.
   PubMed Web of Science ®Google Scholar
• Lee YS, Choi H, Cho H-R, Son W-C, Park Y-S, Kang C-D, Bae J. Downregulation of NKG2DLs by TGF-β in human lung cancer cells. BMC Immunol. 2021;22(1):44. doi:10.1186/s12865-021-00434-8.
   PubMed Web of Science ®Google Scholar
• Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576–590. doi:10.1016/j.ccr.2011.09.009.
   PubMed Web of Science ®Google Scholar
• Buchheit CL, Weigel KJ, Schafer ZT. Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat Rev Cancer. 2014;14(9):632–641. doi:10.1038/nrc3789.
   PubMed Web of Science ®Google Scholar
• Haemmerle M, Taylor ML, Gutschner T, Pradeep S, Cho MS, Sheng J, Lyons YM, Nagaraja AS, Dood RL, Wen Y, et al. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling. Nat Commun. 2017;8(1):310. doi:10.1038/s41467-017-00411-z.
   PubMedGoogle Scholar
• Labelle M, Begum S, Hynes RO. Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci USA. 2014;111(30):E3053–E3061. doi:10.1073/pnas.1411082111.
   PubMed Web of Science ®Google Scholar
• Ishikawa S, Miyashita T, Inokuchi M, Hayashi H, Oyama K, Tajima H, Takamura H, Ninomiya I, Ahmed AK, Harman JW, et al. Platelets surrounding primary tumor cells are related to chemoresistance. Oncol Rep. 2016;36(2):787–794. doi:10.3892/or.2016.4898.
   PubMed Web of Science ®Google Scholar
• Moore RA, Adel N, Riedel E, Bhutani M, Feldman DR, Tabbara NE, Soff G, Parameswaran R, Hassoun H. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol. 2011;29(25):3466–3473. doi:10.1200/JCO.2011.35.5669.
   PubMed Web of Science ®Google Scholar
• Radziwon-Balicka A, Medina C, O’Driscoll L, Treumann A, Bazou D, Inkielewicz-Stepniak I, Radomski A, Jow H, Radomski MW. Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance. Br J Pharmacol. 2012;167(4):787–804. doi:10.1111/j.1476-5381.2012.01991.x.
   PubMed Web of Science ®Google Scholar
• Volz J, Mammadova-Bach E, Gil-Pulido J, Nandigama R, Remer K, Sorokin L, Zernecke A, Abrams SI, Ergün S, Henke E, et al. Inhibition of platelet GPVI induces intratumor hemorrhage and increases efficacy of chemotherapy in mice. Blood. 2019;133(25):2696–2706. doi:10.1182/blood.2018877043.
   PubMed Web of Science ®Google Scholar
• Demers M, Ho-Tin-Noé B, Schatzberg D, Yang JJ, Wagner DD. Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice. Cancer Res. 2011;71(5):1540–1549. doi:10.1158/0008-5472.CAN-10-2038.
   PubMed Web of Science ®Google Scholar
• Haemmerle M, Bottsford-Miller J, Pradeep S, Taylor ML, Choi HJ, Hansen JM, Dalton HJ, Stone RL, Cho MS, Nick AM, et al. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. J Clin Invest. 2016;126(5):1885–1896. doi:10.1172/JCI85086.
   PubMed Web of Science ®Google Scholar
• Elaskalani O, Berndt MC, Falasca M, Metharom P. Targeting platelets for the treatment of cancer. Cancers Basel. 2017;9(7):94. doi:10.3390/cancers9070094.
   PubMed Web of Science ®Google Scholar
• Huang Y, Lichtenberger LM, Taylor M, Bottsford-Miller JN, Haemmerle M, Wagner MJ, Lyons Y, Pradeep S, Hu W, Previs RA, et al. Antitumor and antiangiogenic effects of aspirin-PC in ovarian cancer. Mol Cancer Ther. 2016;15(12):2894–2904. doi:10.1158/1535-7163.MCT-16-0074.
   PubMed Web of Science ®Google Scholar
• Mitamura T, Gourley C, Sood AK. Prediction of anti-angiogenesis escape. Gynecol Oncol. 2016;141(1):80–85. doi:10.1016/j.ygyno.2015.12.033.
   PubMed Web of Science ®Google Scholar
• Xu Z, Li E, Guo Z, Yu R, Hao H, Xu Y, Sun Z, Li X, Lyu J, Wang Q. Design and construction of a multi-organ microfluidic chip mimicking the in vivo microenvironment of lung cancer metastasis. ACS Appl Mater Interfaces. 2016;8(39):25840–25847. doi:10.1021/acsami.6b08746.
   PubMed Web of Science ®Google Scholar
• Nagaraju S, Truong D, Mouneimne G, Nikkhah M. Microfluidic tumor-vascular model to study breast cancer cell invasion and intravasation. Adv Healthcare Mater. 2018;7(9):e1701257. doi:10.1002/adhm.201701257.
   Web of Science ®Google Scholar
• Chen MB, Whisler JA, Fröse J, Yu C, Shin Y, Kamm RD. On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics. Nat Protoc. 2017;12(5):865–880. doi:10.1038/nprot.2017.018.
   PubMed Web of Science ®Google Scholar
• Jeon JS, Bersini S, Gilardi M, Dubini G, Charest JL, Moretti M, Kamm RD. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc Natl Acad Sci USA. 2015;112(1):214–219. doi:10.1073/pnas.1417115112.
   PubMed Web of Science ®Google Scholar
• Kim S, Lee H, Chung M, Jeon NL. Engineering of functional, perfusable 3D microvascular networks on a chip. Lab Chip. 2013;13(8):1489–1500. doi:10.1039/c3lc41320a.
   PubMed Web of Science ®Google Scholar
• Jain A, Barrile R, van der Meer AD, Mammoto A, Mammoto T, De Ceunynck K, Aisiku O, Otieno MA, Louden CS, Hamilton GA, et al. Primary human lung alveolus-on-a-chip model of intravascular thrombosis for assessment of therapeutics. Clin Pharmacol Ther. 2018;103(2):332–340. doi:10.1002/cpt.742.
   PubMed Web of Science ®Google Scholar
• Jain A, Graveline A, Waterhouse A, Vernet A, Flaumenhaft R, Ingber DE. A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function. Nat Commun. 2016;7(1):10176. doi:10.1038/ncomms10176.
   PubMedGoogle Scholar
• Jain A, van der Meer AD, Papa AL, Barrile R, Lai A, Schlechter BL, Otieno MA, Louden CS, Hamilton GA, Michelson AD, et al. Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium. Biomed Microdevices. 2016;18(4):73. doi:10.1007/s10544-016-0095-6.
   PubMed Web of Science ®Google Scholar
• Saha B, Mathur T, Handley KF, Hu W, Afshar-Kharghan V, Sood AK, Jain A. OvCa-chip microsystem recreates vascular endothelium–mediated platelet extravasation in ovarian cancer. Blood Adv. 2020;4(14):3329–3342. doi:10.1182/bloodadvances.2020001632.
   PubMed Web of Science ®Google Scholar
• Saha B, Mathur T, Tronolone JJ, Chokshi M, Lokhande GK, Selahi A, Gaharwar AK, Afshar-Kharghan V, Sood AK, Bao G, et al. Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer. Sci Adv. 2021;7(30):eabg5283. doi:10.1126/sciadv.abg5283.
   PubMed Web of Science ®Google Scholar
• Crippa M, Bersini S, Gilardi M, Arrigoni C, Gamba S, Falanga A, Candrian C, Dubini G, Vanoni M, Moretti M. Correction: a microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β3 impact breast cancer cell extravasation. Lab Chip. 2021;21(6):1185–1185. doi:10.1039/D1LC90024B.
   PubMed Web of Science ®Google Scholar
• Papa A-L, Jiang A, Korin N, Chen MB, Langan ET, Waterhouse A, Nash E, Caroff J, Graveline A, Vernet A, et al. Platelet decoys inhibit thrombosis and prevent metastatic tumor formation in preclinical models. Sci Transl Med. 2019;11(479):eaau5898. doi:10.1126/scitranslmed.aau5898.
   PubMed Web of Science ®Google Scholar
• Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5(3):632–634. doi:10.1111/j.1538-7836.2007.02374.x.
   PubMed Web of Science ®Google Scholar
• Estrada R, Giridharan GA, Nguyen MD, Prabhu SD, Sethu P. Microfluidic endothelial cell culture model to replicate disturbed flow conditions seen in atherosclerosis susceptible regions. Biomicrofluidics. 2011;5(3):32006–32011. doi:10.1063/1.3608137.
   PubMed Web of Science ®Google Scholar
• Mannino RG, Myers DR, Ahn B, Wang Y, Margo R, Gole H, Lin AS, Guldberg RE, Giddens DP, Timmins LH, et al. Do-it-yourself in vitro vasculature that recapitulates in vivo geometries for investigating endothelial-blood cell interactions. Sci Rep. 2015;5(1):12401. doi:10.1038/srep12401.
   PubMedGoogle Scholar
• Zhang YS, Aleman J, Shin SR, Kilic T, Kim D, Mousavi Shaegh SA, Massa S, Riahi R, Chae S, Hu N, et al. Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proc Natl Acad Sci USA. 2017;114(12):E2293–E2302. doi:10.1073/pnas.1612906114.
   PubMed Web of Science ®Google Scholar
• McMinn PH, Hind LE, Huttenlocher A, Beebe DJ. Neutrophil trafficking on-a-chip: an in vitro , organotypic model for investigating neutrophil priming, extravasation, and migration with spatiotemporal control. Lab Chip. 2019;19(21):3697–3705. doi:10.1039/C9LC00562E.
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Cherepanov V, Cabrera-Fuentes HA, Kim MH. Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges. Thromb Haemost. 2015;114(6):1104–1112. doi:10.1160/TH15-01-0077.
   PubMed Web of Science ®Google Scholar
• Gard AL, Luu RJ, Miller CR, Maloney R, Cain BP, Marr EE, Burns DM, Gaibler R, Mulhern TJ, Wong CA, et al. High-throughput human primary cell-based airway model for evaluating influenza, coronavirus, or other respiratory viruses in vitro. Sci Rep. 2021;11(1):14961. doi:10.1038/s41598-021-94095-7.
   PubMed Web of Science ®Google Scholar
• van Meer BJ, de Vries H, Firth KSA, van Weerd J, Tertoolen LGJ, Karperien HBJ, Jonkheijm P, Denning C, IJzerman AP, Mummery CL. Small molecule absorption by PDMS in the context of drug response bioassays. Biochem Biophys Res Commun. 2017;482(2):323–328. doi:10.1016/j.bbrc.2016.11.062.
   PubMed Web of Science ®Google Scholar
• Domansky K, Sliz JD, Wen N, Hinojosa C, Thompson G, Fraser JP, Hamkins-Indik T, Hamilton GA, Levner D, Ingber DE. SEBS elastomers for fabrication of microfluidic devices with reduced drug absorption by injection molding and extrusion. Microfluid Nanofluidics. 2017;21(6):107. doi:10.1007/s10404-017-1941-4.
   Web of Science ®Google Scholar
• Schneider S, Brás EJS, Schneider O, Schlünder K, Loskill P. Facile patterning of thermoplastic elastomers and robust bonding to glass and thermoplastics for microfluidic cell culture and organ-on-chip. Micromachines (Basel). 2021;12(5):575. doi:10.3390/mi12050575.
   PubMed Web of Science ®Google Scholar
• Baran SW, Brown PC, Baudy AR, Fitzpatrick SC, Frantz C, Fullerton A, Gan J, Hardwick RN, Hillgren KM, Kopec AK, et al. Perspectives on the evaluation and adoption of complex in vitro models in drug development: workshop with the FDA and the pharmaceutical industry (IQ MPS affiliate). Altex. 2022;39(2). doi:10.14573/altex.2112203.
   PubMedGoogle Scholar
• Bhattacharjee N, Urrios A, Kang S, Folch A. The upcoming 3D-printing revolution in microfluidics. Lab Chip. 2016;16(10):1720–1742. doi:10.1039/C6LC00163G.
   PubMed Web of Science ®Google Scholar